AorticLab S.r.l. today announce sits clear victory before the Court of First Instance of the Unified Patent Court (UPC), Local Division Munich, following the comprehensive dismissal of the patent ...
Fluidx Medical Technology, Inc. announced the completion of patient enrollment in the investigational device exemption (IDE) piv ...
Boston Scientific suspended sales of its second-generation Watchman FLX device after reports of device embolization during a limited market rollout. As doctors in Europe began implanting the product ...
Austin, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Embolic Protection Devices Market Size and Growth Analysis: According to SNS Insider, the global Embolic Protection Devices Market was valued at USD 656.60 ...
SALT LAKE CITY, UTAH, UNITED STATES , May 21, 2024 /EINPresswire.com/ -- Fluidx Medical Technology, Inc. announced today that the FDA has granted Investigational ...
United States Embolic Protection Device Market is expected to reach US$ 650 million by 2033 from US$ 360 million in 2024, with a CAGR of 6.96% from 2025 to 2033. Rising cardiovascular operations, ...
LONDON, Feb. 27, 2018 /PRNewswire/ -- Global embolic protection devices market projected to grow at a CAGR of 8.3% The global embolic protection devices market is projected to reach USD 604.9 million ...
A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback